Efficacy of Risankizumab compared with placebo across subgroups in patients with moderate-to-severe plaque psoriasis: integrated analyses from three phase 3 trials

Lebwohl M.; Ghislain P.; Kerdel F.; Gu Y.; Valdes J. M.; Thompson E. H.; Lynde C.

首页> 外文期刊>Experimental dermatology >Efficacy of Risankizumab compared with placebo across subgroups in patients with moderate-to-severe plaque psoriasis: integrated analyses from three phase 3 trials

【24h】

Efficacy of Risankizumab compared with placebo across subgroups in patients with moderate-to-severe plaque psoriasis: integrated analyses from three phase 3 trials

机译：Risankizumab与安慰剂与中度患者中度至重度斑块牛皮癣患者的安慰剂的疗效：来自三阶段3试验的综合分析

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Experimental dermatology》 |2019年第3期|共1页
作者
Lebwohl M.; Ghislain P.; Kerdel F.; Gu Y.; Valdes J. M.; Thompson E. H.; Lynde C.;
展开▼
作者单位

Icahn Sch Med Mt Sinai New York NY 10029 USA;

UCL St Luc Brussels Belgium;

Florida Acad Dermatol Ctr Miami FL USA;

AbbVie Inc Chicago IL USA;

AbbVie Inc Chicago IL USA;

AbbVie Inc Redwood City CA USA;

Lynde Ctr Dermatol &

Prob Med Res Markham ON Canada;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类皮肤病学与性病学;
关键词

相似文献

外文文献
中文文献
专利

1. Efficacy of Risankizumab compared with placebo across subgroups in patients with moderate-to-severe plaque psoriasis: integrated analyses from three phase 3 trials [J] . Lebwohl M., Ghislain P., Kerdel F., Experimental dermatology . 2019,第3期

机译：Risankizumab与安慰剂与中度患者中度至重度斑块牛皮癣患者的安慰剂的疗效：来自三阶段3试验的综合分析
2. Efficacy and safety of Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis: Results from the Phase 3 IMMvent trial [J] . Reich K., Gooderham M., Thaci D., Experimental dermatology . 2019,第3期

机译：与中度至严重的斑块牛皮癣患者的患者血清单抗的功效和安全性：第3期免疫试验结果
3. Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials [J] . Gordon Kenneth B., Strober Bruce, Lebwohl Mark, The Lancet . 2018,第10148期

机译：Risankizumab在中度至重度斑块牛皮癣中的功效和安全性（Ultimma-1和Ultimma-2）：两种双盲，随机，安慰剂控制和Ustekukumab控制相3试验结果
4. A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED CLINICAL TRIAL TO INVESTIGATE THE EFFICACY OF TIAMULIN IN THE CONTROL OF PORCINE PROLIFERATIVE ENTEROPATHY (PPE) AND PORCINE COLONIC SPIROCHAETOSIS (PCS) UNDER FIELD CONDITIONS [C] . J. Haugegaard, K. Moller, T.K. Jensen, Congress of the International Pig Veterinary Society . 2000

机译：一种双盲随机安慰剂对照临床试验，探讨硫霉素在野生植物中猪增殖肠病（PPE）和猪结肠螺旋肌肤症（PCS）的疗效
5. A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil (Eicosapentaenoic Acid and Docosahexaenoic Acid) on Lung and Systemic Inflammation in Patients with Acute Lung Injury. [D] . Stapleton, Renee Doney. 2010

机译：鱼油（二十碳五烯酸和二十二碳六烯酸）对急性肺损伤患者的肺和全身炎症的II期，随机，双盲，安慰剂对照试验。
6. Long-Term Safety and Efficacy of Risankizumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: Results from a Phase 2 Open-Label Extension Trial [O] . Kim A. Papp, Saskia de Vente, Jiewei Zeng, 2021

机译：Risankizumab在中度至严重的慢性牙菌斑牛皮癣患者中的长期安全性和功效：2阶段2开放标签扩展试验的结果
7. Efficacy of ixekizumab compared to etanercept and placebo in patients with moderate-to-severe plaque psoriasis and non-pustular palmoplantar involvement:Results from three phase 3 trials (UNCOVER-1, UNCOVER-2 and UNCOVER-3) [O] . Menter, A, Warren, R. B., Langley, R. G., 2018

机译：ixekizumab与依那西普和安慰剂相比，对中重度斑块状银屑病和非脓疱性掌跖受累患者的疗效：三项3期试验（UNCOVER-1，UNCOVER-2和UNCOVER-3）的结果

Efficacy of Risankizumab compared with placebo across subgroups in patients with moderate-to-severe plaque psoriasis: integrated analyses from three phase 3 trials

著录项

相似文献

相关主题

期刊订阅